{"id":"W4309165886","doi":"10.3899/jrheum.220353","title":"Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial","year":2022,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Celgene; Gilead Sciences; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Etanercept; Internal medicine; Clinical endpoint; Ankylosing spondylitis; Univariate analysis; Gastroenterology; Surgery; Clinical trial; Multivariate analysis; Rheumatoid arthritis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003853983,0.0009844243,0.001864917,0.0002558259,0.0002626905,0.000837155,0.0006059108,0.0009876211,0.001648097],"category_scores_gemma":[0.002100484,0.0002958697,0.001444059,0.0002678628,0.0004797308,0.0007369434,0.0002205172,0.002016961,0.0002907773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005735896,"about_ca_system_score_gemma":0.0008691815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006760755,"about_ca_topic_score_gemma":0.002114832,"domain_scores_codex":[0.998899,0.0006955992,0.00009622701,0.0001004076,0.0001004679,0.0001082623],"domain_scores_gemma":[0.9981936,0.0007780954,0.0004019667,0.0001064641,0.0001266143,0.0003933693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.881113,0.02274974,0.01047791,0.001427033,0.002601942,0.0001616177,0.0002408481,0.0008368133,0.005846942,0.00007881803,0.00121922,0.07324604],"study_design_scores_gemma":[0.6610227,0.2863805,0.04755636,0.0001444142,0.001268227,0.0003325033,0.0000860109,0.001040737,0.001026838,0.00007009202,0.001041393,0.00003035568],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944476,0.003973754,0.0001590642,0.000157687,0.00004257413,0.0003851473,0.0003621874,0.00002126983,0.0004507215],"genre_scores_gemma":[0.9940055,0.00225912,0.0005671309,0.0003986478,0.0001825443,0.0006214477,0.0009961677,0.000009149571,0.0009602574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003853983,"threshold_uncertainty_score":0.02038205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03374858037040936,"score_gpt":0.326691480081566,"score_spread":0.2929428997111567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}